Erythrasma is a skin condition that affects the skin, usually in the groin, armpits, or between the toes. It is a bacterial infection that causes a red, scaly rash. It is often misdiagnosed as a fungal infection, which can lead to unnecessary treatment and prolonged suffering. In this article, we will discuss the causes, symptoms, diagnosis, and treatment of erythrasma. We will also provide tips on how to prevent and manage the condition.
Erythrasma is a bacterial infection of the skin caused by the Corynebacterium minutissimum bacteria. It usually affects the groin, armpits, or between the toes. It is characterized by a red, scaly rash that can be itchy or painful. It is most common in people who are overweight or who have diabetes. It is also more common in people with a weakened immune system.
Erythrasma is caused by the Corynebacterium minutissimum bacteria. This bacteria is normally found on the skin, but in some cases, it can overgrow and cause an infection. Factors that can increase the risk of erythrasma include: • Being overweight • Having diabetes • Having a weakened immune system • Poor hygiene • Wearing tight, non-breathable clothing • Living in a warm, humid climate
The main symptom of erythrasma is a red, scaly rash. The rash typically appears in the groin, armpits, or between the toes. It may also appear on other areas of the body, such as the abdomen, chest, or back. Other symptoms of erythrasma include itching, burning, and pain.
Erythrasma is usually diagnosed based on the appearance of the rash. Your doctor may also take a sample of the rash and examine it under a microscope. This is done to rule out other possible causes of the rash, such as a fungal infection.
Erythrasma is usually treated with antibiotics. These antibiotics can be taken orally or applied topically. In some cases, your doctor may recommend a combination of both. Treatment usually lasts for several weeks.
Erythrasma can be prevented by practicing good hygiene, wearing loose-fitting, breathable clothing, and avoiding hot, humid climates. If you have erythrasma, it is important to keep the area clean and dry. Avoiding tight clothing and using an antifungal powder can also help manage the condition.
Erythrasma is a bacterial infection of the skin that is often misdiagnosed as a fungal infection. It is characterized by a red, scaly rash that can be itchy or painful. The condition is caused by the Corynebacterium minutissimum bacteria and is more common in people who are overweight or have diabetes. Treatment usually involves antibiotics, and prevention involves practicing good hygiene and wearing loose-fitting clothing. If you have erythrasma, it is important to keep the area clean and dry and avoid tight clothing. With the right treatment and prevention measures, you can manage erythrasma and reduce your risk of recurrence.
1.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
2.
How artificial intelligence could significantly improve the prognosis for cancer patients.
3.
Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.
4.
Overdosing on Chemotherapy: A Single Gene Test Could Prevent Hundreds of Deaths Annually.
5.
Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.
1.
Understanding Neutrophilia: Causes, Symptoms, and Treatment Options
2.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
3.
A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology
4.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
5.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation